Stefan Leucht

Active 1999–2026

277
Papers
51,967
Citations
121
h-index
255
i10-index

Citations

Citations per year for Stefan Leucht1978: 1 citations1999: 4 citations2000: 13 citations2001: 16 citations2002: 26 citations2003: 36 citations2004: 48 citations2005: 83 citations2006: 112 citations2007: 134 citations2008: 143 citations2009: 171 citations2010: 257 citations2011: 286 citations2012: 326 citations2013: 322 citations2014: 331 citations2015: 310 citations2016: 291 citations2017: 392 citations2018: 388 citations2019: 1,500 citations2020: 1,613 citations2021: 1,545 citations2022: 1,345 citations2023: 1,030 citations2024: 1,978 citations2025: 920 citations2026: 57 citations1979–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,162 citing papers, 17.7% of this breakdownUnited Kingdom: 1,949 citing papers, 10.9% of this breakdownGermany: 1,382 citing papers, 7.8% of this breakdownChina: 1,156 citing papers, 6.5% of this breakdownCanada: 1,042 citing papers, 5.8% of this breakdownAustralia: 878 citing papers, 4.9% of this breakdownItaly: 813 citing papers, 4.6% of this breakdownNetherlands: 628 citing papers, 3.5% of this breakdownSpain: 597 citing papers, 3.3% of this breakdownSwitzerland: 515 citing papers, 2.9% of this breakdownJapan: 403 citing papers, 2.3% of this breakdownFrance: 402 citing papers, 2.3% of this breakdown
0%17.7%Other 27.5%

Fields

  • Medicine57.3%
  • Neuroscience16.5%
  • Psychology9.6%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Health Professions2.5%
  • Pharmacology, Toxicology and Pharmaceutics2.1%
  • Other6.4%

Topics

  • Schizophrenia research and treatment13.6%
  • Treatment of Major Depression5%
  • Tryptophan and brain disorders4.9%
  • Bipolar Disorder and Treatment4.1%
  • Mental Health and Psychiatry2.5%
  • Functional Brain Connectivity Studies2.4%
  • Other67.5%

Coauthors

All papers

Open in search
  1. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2018 cited by 3,459

  2. Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis

    Authors: , , , , , , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 cited by 1,744

  3. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

    Authors: , , , - Schizophrenia Bulletin 2016 cited by 744

  4. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    Authors: , , , , , , , , , , , , , , - The Lancet 2013 cited by 2,537

  5. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

    Authors: , , , , , , , , , , , , - World Psychiatry 2011 cited by 2,495

  6. Living systematic review: 1. Introduction—the why, what, when, and how

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriel Rada, Matthew K. Bagg, Arwel W. Jones, Philippe Ravaud, Catherine Boden, Lara A Kahale, Bernt Richter, Isabelle Boisvert, Homa Keshavarz, Rebecca Ryan, Linn Brandt, Stephanie A. Kolakowsky‐Hayner, Dina H. Salama, Alexandra Bražinová, Sumanth Kumbargere Nagraj, Georgia Salanti, Rachelle Buchbinder, Toby J Lasserson, Lina Santaguida, Chris Champion, Rebecca Lawrence, Nancy Santesso, Jackie Chandler, Zbigniew Leś, Holger J. Schünemann, Andreas Charidimou, Stefan Leucht, Ian Shemilt, Roger Chou, Nicola Low, Diana Sherifali, Rachel Churchill, Andrew I.R. Maas, Reed Siemieniuk, Maryse C. Cnossen, Harriet MacLehose, Mark Simmonds, Marie-Joëlle Cossi, Malcolm Macleod, Nicole Skoetz, Michel Jacques Counotte, Iain Marshall, Karla Soares‐Weiser, Samantha Craigie, Iain Marshall, Velandai Srikanth, Philipp Dahm, Nicole Martin, Katrina Sullivan, Alanna Danilkewich, Laura Martínez García, Anneliese Synnot, Kristen Danko, Chris Mavergames, Mark Taylor, Emma Donoghue, Lara Maxwell, Kris Thayer, Corinna Dressler, James H. McAuley, James Thomas, Cathy Egan, Steve McDonald, Roger Tritton, Julian Elliott, Joanne E. McKenzie, Guy Tsafnat, Sarah A. Elliott, Joerg J Meerpohl, Peter Tugwell and 44 more - Journal of Clinical Epidemiology 2017 cited by 671

  7. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , - The Lancet 2022 cited by 216

  8. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 737

  9. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

    Authors: , , , , , , , , , , , , - American Journal of Psychiatry 2017 cited by 536

  10. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

    Authors: , , , , , - The Lancet 2008 cited by 1,916

  11. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

    Authors: , , , , , - American Journal of Psychiatry 2019 cited by 294

  12. Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development

    Authors: , , , , , , , , , , , - The Lancet Psychiatry 2023 cited by 137

  13. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 351

  14. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

    Authors: , , , , , , , , - Journal of Affective Disorders 2015 cited by 393

  15. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

    Authors: , , , , , , - The Lancet 2012 cited by 923

  16. Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art

    Authors: , , , , , , , , - Schizophrenia Research Cognition 2022 cited by 161

  17. Living systematic reviews: 4. Living guideline recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Homa Keshavarz, Rebecca Ryan, Linn Brandt, Stephanie A. Kolakowsky‐Hayner, Dina H. Salama, Alexandra Bražinová, Sumanth Kumbargere Nagraj, Georgia Salanti, Rachelle Buchbinder, Toby J Lasserson, Lina Santaguida, Chris Champion, Rebecca Lawrence, Nancy Santesso, Jackie Chandler, Zbigniew Leś, Holger J. Schünemann, Andreas Charidimou, Stefan Leucht, Ian Shemilt, Roger Chou, Nicola Low, Diana Sherifali, Rachel Churchill, Andrew I.R. Maas, Reed Siemieniuk, Maryse C. Cnossen, Harriet MacLehose, Mark Simmonds, Marie-Joëlle Cossi, Malcolm Macleod, Nicole Skoetz, Michel Jacques Counotte, Iain Marshall, Karla Soares‐Weiser, Samantha Craigie, Iain Marshall, Velandai Srikanth, Philipp Dahm, Nicole Martin, Katrina Sullivan, Alanna Danilkewich, Laura Martínez García, Anneliese Synnot, Kristen Danko, Chris Mavergames, Mark Taylor, Emma Donoghue, Lara Maxwell, Kris Thayer, Corinna Dressler, James H. McAuley, James Thomas, Cathy Egan, Steve McDonald, Roger Tritton, Julian Elliott, Joanne E. McKenzie, Guy Tsafnat, Sarah A. Elliott, Joerg J Meerpohl, Peter Tugwell, Itziar Etxeandia‐Ikobaltzeta, Bronwen Merner, Alexis F. Turgeon, Robin Featherstone, Stefania Mondello, Tari Turner, Ruth Foxlee, Richard Morley and 36 more - Journal of Clinical Epidemiology 2017 cited by 339

  18. Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis

    Authors: , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2019 cited by 317

  19. Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

    Authors: , , , , , , , , - Translational Psychiatry 2021 cited by 169

  20. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , - The Lancet Psychiatry 2021 cited by 265

  21. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

    Authors: , , , , , - Schizophrenia Bulletin 2014 cited by 374

  22. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

    Authors: , , , , , , , , , , , , , , , , - JAMA Psychiatry 2022 cited by 124

  23. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis

    Authors: , , , , - The Lancet Psychiatry 2023 cited by 98

  24. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

    Authors: , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2022 cited by 208